BioHealth News Archive
Novavax Candidate COVID-19 Vaccine Moves into Phase III Trial
The National Institute of Allergy and Infectious Diseases (NIAID) announced the commencement of the Phase III trial (NCT04611802) of the Novavax investigational COVID-19 vaccine,…
Read More
How I Lost 65 Pounds In 18 Months Without Any Fad Diets or Gimmicks | by Mark Suster | Jan, 2021 | Both Sides of the Table
I’ve been reluctant to write this blog post because historically I don’t like talking about weight. But I’ve been promising to publish how I…
Read More
Biotech Showcase™ | Investor conference | Co-produced by Demy-Colton and EBD Group
We are now only a few weeks out from Biotech Showcase and excited to launch the Spotlight Sessions on our on-demand hub on partneringONE.…
Read More
7 Cell Therapy Companies in Maryland Helping to Revolutionize Drug Discovery: The Latest News | American Gene Technologies
Maryland is home to one of the largest life science clusters in the United States with more than 500 biotech companies. In addition to…
Read More
Emmes Acquires Neox s.r.o., a Clinical Research Organization Headquartered in the Czech Republic
ROCKVILLE, Md., Dec. 30, 2020 /PRNewswire/ -- Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical…
Read More
U.K. Authorizes Covid-19 Vaccine From Oxford and AstraZeneca – The New York Times
LONDON — Britain on Wednesday became the first country to give emergency authorization to the coronavirus vaccine developed by AstraZeneca and the University of…
Read More
Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and Mexico | Novavax Inc. – IR Site
GAITHERSBURG, Md., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today…
Read More
REGENXBIO Announces Agreement to Monetize Portion of Zolgensma® Royalties for $200 Million | BioSpace
ROCKVILLE, Md., Dec. 22, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of…
Read More
REGENXBIO Announces Agreement to Monetize Portion of Zolgensma® Royalties for $200 Million | BioSpace
ROCKVILLE, Md., Dec. 22, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of…
Read MoreExclusive: D.C. med-tech startup Nanochon raising new funding for 3D-printed implant for joint injuries – Washington Business Journal
Nanochon is aiming to close the round in January to fund the first human study of its product. Image: Ben Holmes is co-founder and…
Read More
Genetically Modified Pigs May Save Your Life: FDA Allows GMO Pigs
The U.S. Food and Drug Administration (FDA) has approved the second-ever genetically modified subtype of pig for human consumption. But there are no plans…
Read More
Genetically Modified Pigs May Save Your Life: FDA Allows GMO Pigs
The U.S. Food and Drug Administration (FDA) has approved the second-ever genetically modified subtype of pig for human consumption. But there are no plans…
Read More
These breakthroughs will make 2021 better than 2020 | LinkedIn
The latest on the innovations that will let us go back to normal. This has been a devastating year. More than 1.6 million people…
Read More
Virginia Bio Will Direct New “Virginia Bio-Connect” Statewide Consortium to Strengthen Competitiveness of Virginia’s Life Science Ecosystem | Business Wire
RICHMOND, Va.--(BUSINESS WIRE)--Governor Northam and the Virginia Biotechnology Association announced today that GO Virginia has approved a competitive grant request to help fund Virginia…
Read More
Task force report outlines steps to build stronger post-pandemic economy in Maryland, Virginia, D.C. – The Washington Post
More than 50 local leaders have mapped out an economic recovery strategy for the Washington area that they say would leave it more unified,…
Read More